Please enable JavaScript to continue using this application.

Compare $CRVS vs $OBX | Chartloom

Compare

$CRVS vs $OBX

Corvus Pharmaceuticals Inc · Obsidian Therapeutics, Inc

CRVS

Corvus Pharmaceuticals Inc

OBX

Obsidian Therapeutics, Inc

Compare $CRVS vs $OBX

Comparing Corvus Pharmaceuticals Inc and Obsidian Therapeutics, Inc

CRVSCorvus Pharmaceuticals Inc

OBXObsidian Therapeutics, Inc

CRVSCorvus Pharmaceuticals Inc

Market cap

$885M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

43.7%

52W performance

50.3%

FCF yield

-5.1%

OBXObsidian Therapeutics, Inc

Market cap

$803M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-61.8%

52W performance

-61.8%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRVS

OBX

Detailed metrics comparison

CRVS

Corvus Pharmaceuticals Inc

OBX

Obsidian Therapeutics, Inc

Market Cap

CRVS$885M

OBX$803M

Enterprise Value

CRVS$866M

OBX$803M

Price

CRVS$10.52

OBX$13.00

P/E Ratio

CRVSN/A

OBXN/A

P/S Ratio

CRVS0.00x

OBX0.00x

EV/Sales

CRVS0.00x

OBX0.00x

EV/EBITDA

CRVS0.00x

OBX0.00x

P/B Ratio

CRVS4.07x

OBXN/A

P/FCF Ratio

CRVSN/A

OBXN/A

EV/FCF

CRVS-19.14x

OBX0.00x

PEG Ratio

CRVSN/A

OBXN/A

Forward P/E (NTM)

CRVSN/A

OBXN/A

Forward P/S (NTM)

CRVSN/A

OBXN/A

Revenue (TTM)

CRVS$0

OBX$0

Revenue Growth (YoY)

CRVSN/A

OBXN/A

Forward Rev Growth

CRVS1220.6%

OBX0.0%

Gross Margin (TTM)

CRVS0.0%

OBX0.0%

Operating Margin (TTM)

CRVS0.0%

OBX0.0%

EBITDA Margin (TTM)

CRVS0.0%

OBX0.0%

Net Margin (TTM)

CRVS0.0%

OBX0.0%

FCF Margin (TTM)

CRVSN/A

OBXN/A

Net Income (TTM)

CRVS$-54M

OBXN/A

FCF (TTM)

CRVS$-45M

OBX$0

EPS (TTM)

CRVS-$0.59

OBX$0.00

ROE (TTM)

CRVS-3615.0%

OBX0.0%

ROA (TTM)

CRVS-3362.0%

OBX0.0%

ROIC (TTM)

CRVS-3615.0%

OBX0.0%

Cash

CRVS$19M

OBX$0

Debt

CRVS$0

OBX$0

Net Cash/Debt

CRVS$19M

OBX$0

Current Ratio (TTM)

CRVS16.16x

OBX0.00x

Quick Ratio (TTM)

CRVS15.92x

OBX0.00x

Debt/Equity (TTM)

CRVS0.00x

OBX0.00x

Debt/Assets (TTM)

CRVS0.0%

OBX0.0%

Interest Coverage (TTM)

CRVSN/A

OBXN/A

Net Debt/EBITDA (TTM)

CRVS0.00x

OBX0.00x

Beta

CRVS1.59

OBX5.86

52W Performance

CRVS50.3%

OBX-61.8%

YTD Performance

CRVS43.7%

OBX-61.8%

% from 52W High

CRVS-61.0%

OBX-74.0%

% from 52W Low

CRVS64.6%

OBX7.7%

Asset Turnover (TTM)

CRVS0.00x

OBX0.00x

FCF Yield (TTM)

CRVS-5.1%

OBX0.0%

Earnings Yield (TTM)

CRVS-6.1%

OBX0.0%

Dividend Yield (TTM)

CRVSN/A

OBXN/A

Rule of 40

CRVS0.0

OBX0.0

EV/GP/RG

CRVSN/A

OBXN/A

Ticker research

View CRVS research View OBX research

Metric	CRVS Corvus Pharmaceuticals Inc	OBX Obsidian Therapeutics, Inc
Market & Valuation
Market Cap	$885M	$803M
Enterprise Value	$866M	$803M
Price	$10.52	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.07x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-19.14x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1220.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-54M	N/A
FCF (TTM)	$-45M	$0
EPS (TTM)	-$0.59	$0.00
ROE (TTM)	-3615.0%	0.0%
ROA (TTM)	-3362.0%	0.0%
ROIC (TTM)	-3615.0%	0.0%
Financial Health
Cash	$19M	$0
Debt	$0	$0
Net Cash/Debt	$19M	$0
Current Ratio (TTM)	16.16x	0.00x
Quick Ratio (TTM)	15.92x	0.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.59	5.86
52W Performance	50.3%	-61.8%
YTD Performance	43.7%	-61.8%
% from 52W High	-61.0%	-74.0%
% from 52W Low	64.6%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.1%	0.0%
Earnings Yield (TTM)	-6.1%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRVS research	View OBX research

Valuation

P/S Ratio

CRVS

0.00x

OBX

0.00x

EV/FCF

CRVS

-19.14x

OBX

0.00x

Growth & revenue

Forward Revenue Growth

CRVS

1220.6%

OBX

0.0%

Profitability & performance

Gross Margin

CRVS

0.0%

OBX

0.0%

ROE

OBX

0.0%

CRVS

-3615.0%

FCF Yield %

OBX

0.0%

CRVS

-5.1%

52-Week Performance

CRVS

50.3%

OBX

-61.8%

Detailed metrics comparison

CRVS

Corvus Pharmaceuticals Inc

OBX

Obsidian Therapeutics, Inc

Market Cap

CRVS$885M

OBX$803M

Enterprise Value

CRVS$866M

OBX$803M

Price

CRVS$10.52

OBX$13.00

P/E Ratio

CRVSN/A

OBXN/A

P/S Ratio

CRVS0.00x

OBX0.00x

EV/Sales

CRVS0.00x

OBX0.00x

EV/EBITDA

CRVS0.00x

OBX0.00x

P/B Ratio

CRVS4.07x

OBXN/A

P/FCF Ratio

CRVSN/A

OBXN/A

EV/FCF

CRVS-19.14x

OBX0.00x

PEG Ratio

CRVSN/A

OBXN/A

Forward P/E (NTM)

CRVSN/A

OBXN/A

Forward P/S (NTM)

CRVSN/A

OBXN/A

Revenue (TTM)

CRVS$0

OBX$0

Revenue Growth (YoY)

CRVSN/A

OBXN/A

Forward Rev Growth

CRVS1220.6%

OBX0.0%

Gross Margin (TTM)

CRVS0.0%

OBX0.0%

Operating Margin (TTM)

CRVS0.0%

OBX0.0%

EBITDA Margin (TTM)

CRVS0.0%

OBX0.0%

Net Margin (TTM)

CRVS0.0%

OBX0.0%

FCF Margin (TTM)

CRVSN/A

OBXN/A

Net Income (TTM)

CRVS$-54M

OBXN/A

FCF (TTM)

CRVS$-45M

OBX$0

EPS (TTM)

CRVS-$0.59

OBX$0.00

ROE (TTM)

CRVS-3615.0%

OBX0.0%

ROA (TTM)

CRVS-3362.0%

OBX0.0%

ROIC (TTM)

CRVS-3615.0%

OBX0.0%

Cash

CRVS$19M

OBX$0

Debt

CRVS$0

OBX$0

Net Cash/Debt

CRVS$19M

OBX$0

Current Ratio (TTM)

CRVS16.16x

OBX0.00x

Quick Ratio (TTM)

CRVS15.92x

OBX0.00x

Debt/Equity (TTM)

CRVS0.00x

OBX0.00x

Debt/Assets (TTM)

CRVS0.0%

OBX0.0%

Interest Coverage (TTM)

CRVSN/A

OBXN/A

Net Debt/EBITDA (TTM)

CRVS0.00x

OBX0.00x

Beta

CRVS1.59

OBX5.86

52W Performance

CRVS50.3%

OBX-61.8%

YTD Performance

CRVS43.7%

OBX-61.8%

% from 52W High

CRVS-61.0%

OBX-74.0%

% from 52W Low

CRVS64.6%

OBX7.7%

Asset Turnover (TTM)

CRVS0.00x

OBX0.00x

FCF Yield (TTM)

CRVS-5.1%

OBX0.0%

Earnings Yield (TTM)

CRVS-6.1%

OBX0.0%

Dividend Yield (TTM)

CRVSN/A

OBXN/A

Rule of 40

CRVS0.0

OBX0.0

EV/GP/RG

CRVSN/A

OBXN/A

Ticker research

View CRVS research View OBX research

Metric	CRVS Corvus Pharmaceuticals Inc	OBX Obsidian Therapeutics, Inc
Market & Valuation
Market Cap	$885M	$803M
Enterprise Value	$866M	$803M
Price	$10.52	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.07x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-19.14x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1220.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-54M	N/A
FCF (TTM)	$-45M	$0
EPS (TTM)	-$0.59	$0.00
ROE (TTM)	-3615.0%	0.0%
ROA (TTM)	-3362.0%	0.0%
ROIC (TTM)	-3615.0%	0.0%
Financial Health
Cash	$19M	$0
Debt	$0	$0
Net Cash/Debt	$19M	$0
Current Ratio (TTM)	16.16x	0.00x
Quick Ratio (TTM)	15.92x	0.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.59	5.86
52W Performance	50.3%	-61.8%
YTD Performance	43.7%	-61.8%
% from 52W High	-61.0%	-74.0%
% from 52W Low	64.6%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.1%	0.0%
Earnings Yield (TTM)	-6.1%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRVS research	View OBX research